<--- Back to Details
First PageDocument Content
Medicine / Clinical medicine / Health / RTT / Ribbon symbolism / Breast cancer / Oncology / Cancer / Metastatic breast cancer / Chemotherapy / National Foundation for Cancer Research / Draft:The Arthur and Sonia Labatt Brain Tumour Research Centre
Date: 2016-08-05 04:35:06
Medicine
Clinical medicine
Health
RTT
Ribbon symbolism
Breast cancer
Oncology
Cancer
Metastatic breast cancer
Chemotherapy
National Foundation for Cancer Research
Draft:The Arthur and Sonia Labatt Brain Tumour Research Centre

Yu Qiang Senior Group Leader Cancer Therapeutics and Stratified Oncology Genome Institute of Singapore New Approaches to Target and Monitor Breast Cancer Progression

Add to Reading List

Source URL: www.imcb.a-star.edu.sg

Download Document from Source Website

File Size: 309,52 KB

Share Document on Facebook

Similar Documents

Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

Bioluminescent orthotopic PDX models of primary pancreatic cancer and residual/metastatic breast cancer to predict efficacy of standard of care and experimental treatments Benjamin G. 1 Cuiffo ,

DocID: 1uQqF - View Document

Jose Falcon Father, Co-Survivor and Veteran Tour de Pink Rider My name is Jose Falcon and I am the proud father and caregiver to my only daughter, Kayla Falcon. She was diagnosed with Stage 4 Metastatic breast cancer at

Jose Falcon Father, Co-Survivor and Veteran Tour de Pink Rider My name is Jose Falcon and I am the proud father and caregiver to my only daughter, Kayla Falcon. She was diagnosed with Stage 4 Metastatic breast cancer at

DocID: 1trwM - View Document

· METASTATIC BREAST CANCER ·  Assessing Treatment Response in Metastatic Breast Cancer Shlomit Strulov Shachar, MD, and Hyman B. Muss, MD  Abstract

· METASTATIC BREAST CANCER · Assessing Treatment Response in Metastatic Breast Cancer Shlomit Strulov Shachar, MD, and Hyman B. Muss, MD Abstract

DocID: 1rmV3 - View Document

Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer

Prolonged disease control by nonmyeloablative allogeneic transplantation for metastatic breast cancer

DocID: 1riiF - View Document

Media release, October 23, 2014  Stopping anti-CCL2 breast cancer treatment aggravates the disease Mohamed Bentires-Alj and his team at the Friedrich Miescher Institute for Biomedical Research (FMI) together with scienti

Media release, October 23, 2014 Stopping anti-CCL2 breast cancer treatment aggravates the disease Mohamed Bentires-Alj and his team at the Friedrich Miescher Institute for Biomedical Research (FMI) together with scienti

DocID: 1rf3r - View Document